Ideaya Biosciences Inc
Company Overview
IDEAYA Biosciences, Inc. is a synthetic lethality-focused precision medicine oncology company. The company's primary focus is on discovering and developing targeted therapeutics for patient populations selected using molecular diagnostics. They are developing potential treatments for various types of cancers using synthetic lethality, targeting specific genetic mutations.
The company is currently in the clinical development stage, with several drug candidates in their pipeline targeting various cancer indications. Their lead programs include IDE397, a MAT2A inhibitor, and darovasertib, a PKC inhibitor.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Ideaya Biosciences Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.